Pune-based Krsnaa Diagnostics, one of India's largest providers of integrated diagnostic services, has announced a strategic investment in cancer and cardiac care hospital Apulki Healthcare, also based in Pune. Under this collaboration, Krsnaa will deliver a comprehensive suite of integrated diagnostic services at Apulki’s facilities, enhancing access to advanced and super specialised diagnostics.

Under this collaboration, Krsnaa Diagnostics will become the exclusive diagnostics partner for Apulki’s state-of-the-art cancer and cardiac hospitals for the next 30+ years. This ensures Krsnaa's sustained leadership in the high-growth oncology and cardiac diagnostic segments, with access to Apulki’s planned network of 10+ hospitals across India.

The initial rollout includes two advanced 125+ bedded hospitals in densely populated regions of Pune and Mumbai, with more hospitals to follow in other metropolitan areas. This initiative will cater to the unmet demand for specialised diagnostics, helping improve outcomes for patients from all socioeconomic backgrounds.

By offering a comprehensive suite of cutting-edge diagnostic technologies including MRI, PET CT, Cardiac CT, and Advanced Pathology, available 24x7 under one roof, Krsnaa and Apulki will provide seamless, world-class diagnostic services for patients undergoing cancer and cardiac treatment. The goal of this partnership is to accelerate early detection, enhance treatment accuracy, and ultimately, improve survival rates through timely and accurate diagnoses.

Yash Mutha, Joint Managing Director of Krsnaa Diagnostics Ltd, stated, “The investment is subject to fulfilment of certain conditions precedent, and the exact amount will be disclosed once we sign the definitive documents. However, it is important to note that this investment will not put any strain on our cash flows, as it will be funded entirely through internal accruals over the next 2-3 months. This partnership also marks a significant milestone for Krsnaa on the retail front, as it enables us to establish comprehensive diagnostic centres in premium urban locations."